Ritalinic acid
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.039.094 |
| Chemical and physical data | |
| Formula | C13H17NO2 |
| Molar mass | 219.284 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Ritalinic acid is a substituted phenethylamine and an inactive major metabolite of the psychostimulant drugs methylphenidate, dexmethylphenidate and ethylphenidate. When administered orally, methylphenidate is extensively metabolized in the liver by hydrolysis of the ester group yielding ritalinic acid. The hydrolysis was found to be catalyzed by carboxylesterase 1 (CES1).
Etymologically, ritalinic acid shares its roots with Ritalin, a common brand name for methylphenidate.